Business EconomyPosted at: Nov 9 2024 9:29PM


Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore

Hyderabad, Nov 9 (UNI) Aurobindo Pharma, an integrated global pharmaceutical company, reported a consolidated net profit of Rs 817 crore for the quarter that ended September 30, 2024, up 8.6 percent from Rs 752 crore a year ago.
Consolidated Revenue from Operations during the quarter increased by 8 percent Y-o-Y to Rs 7,796 crore with growth across the businesses, Hyderabad-based pharma company said in a release here on Saturday.
In Q2FY24, the company’s revenues stood at Rs 7,219 crore
Operational Performance (Consolidated), the company said that its revenues from US formulations (excluding Puerto Rico) increased by 4.3 percent YoY to Rs 3,530 crore (USD 421 million) while from Europe formulations increased by 19 percent YoY to Rs 2,105 crore (EUR 229 million) and growth Markets revenue up by 44 percent YoY to Rs 812 crores (USD 97 million).
The Pharma Company spent Rs 410 crore, 5.3 percent on revenues on Research & Development (R&D including depreciation).
Commenting on the Company’s performance, Aurobindo Vice-Chairman and Managing Director K. Nithyananda Reddy, said: "We are pleased with the continued growth in revenues across our key business areas this quarter, reflecting the resilience of our diversified portfolio. While profitability saw a slight dip, primarily due to the transient nature of certain business activities, our underlying performance remains strong. With a solid foundation and ongoing operational improvements, we are confident of maintaining our growth trajectory and achieving our strategic objectives for the year."
The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally in over 150 countries.
The company has 29 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.
UNI KNR BD
Please log in to get detailed story.
Tags: #Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore
More News

Kedaara Capital appoints Dr Hari Prasad as Operating Advisor

17 Jan 2026 | 6:57 PM

Hyderabad, Jan 17 (UNI) Kedaara Capital today announced the appointment of Dr. Hari Prasad as an Operating Advisor, strengthening the firm’s healthcare advisory capabilities.

see more..

Reliance Posts flat Q3 FY26 profit at Rs 18,645 cr, revenue up by 10 5 per cent

17 Jan 2026 | 5:37 PM

Mumbai, Jan 17 (UNI) Reliance Industries (RIL) has reported a consolidated net profit of Rs 18,645 crore in the third quarter of the financial year 2025-26 (Q3 FY26).

see more..

Mumbai to host first Global Economic Cooperation 2026 from February 17 to 19

17 Jan 2026 | 4:07 PM

New Delhi, Jan 17 (UNI) Senior policymakers, global corporate leaders, investors and heads of multilateral institutions from India and abroad will gather in Mumbai from February 17-19 for the inaugural Global Economic Cooperation 2026, a high-level, invitation-only forum aimed at redefining economic cooperation in an increasingly multipolar global order.

see more..

Growing self-confidence in “New India’s” youth is visible transformation: Piyush Goyal

17 Jan 2026 | 1:00 AM

New Delhi, Jan 16 (UNI) union Minister for Commerce and Industry Piyush Goyal today highlighted that one of the most visible transformations in a resurgent and new India is the growing self-confidence among the country’s youth.
While addressing the “Startup Pe Charcha” interaction at Bharat Mandapam, New Delhi, Minister Goyal highlighted that one of the most visible transformations in a resurgent and new India is the growing self-confidence among the country’s youth.

see more..

Koppert inaugurates expanded Mycorrhiza Production Facility in Hyderabad

16 Jan 2026 | 9:32 PM

Hyderabad, Jan 16 (UNI) Koppert Sustainable Solutions (India) Pvt. Ltd., a global leader in biological solutions for sustainable agriculture, on Friday announced the inauguration of its expanded ‘Mycorrhiza Production Facility’ at IDA Bollaram here on Friday, marking a significant milestone in its commitment to regenerative and environmentally responsible farming in India.

see more..